Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-03-05, Stock:ABBV, The news for the past five days is as follows:
2018-02-26: NEWS1: Johnson & Johnson’s Oncology Segment’s Performance in 2017.NEWS2: Gilead Sciences: The Oncology Company?.NEWS3: Gilead Sciences: The Oncology Company?.NEWS4: AbbVie (ABBV) Up 9.7% Since Earnings Report: Can It Continue?.NEWS5: AbbVie (ABBV) Up 9.7% Since Earnings Report: Can It Continue?.NEWS6: AbbVie to Present at the Barclays Global Healthcare Conference.NEWS7: AbbVie (ABBV) Up 9.7% Since Earnings Report: Can It Continue?.
2018-02-27: NEWS1: 3 Top Pharma Stocks With Dividend Yields Over 3%.NEWS2: Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP.NEWS3: Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP.NEWS4: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS5: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.NEWS6: ABBV Crosses Above Average Analyst Target.NEWS7: ABBV Crosses Above Average Analyst Target.NEWS8: Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP.NEWS9: 3 Reasons AbbVie Inc. Stock Could Keep Soaring in 2018.
2018-02-28: NEWS1: 4 Buy-Ranked Large Cap Pharma Stocks to Boost Your Portfolio.NEWS2: 4 Buy-Ranked Large Cap Pharma Stocks to Boost Your Portfolio.NEWS3: This doctor says his test could decrease opioid addiction.NEWS4: 4 Buy-Ranked Large Cap Pharma Stocks to Boost Your Portfolio.NEWS5: 3 Top Pharma Stocks With Dividend Yields Over 3%.NEWS6: 3 Top Pharma Stocks With Dividend Yields Over 3%.
2018-03-01: NEWS1: Bet on Big Pharma: A Six-Pack of Top Tier Drug Stocks.
2018-03-02: NEWS1: Dow Drops 771 Points This Week as Tariffs, Powell Rough Up Stocks.NEWS2: Biogen, AbbVie Pull Multiple Sclerosis Drug On Inflammation Reports.NEWS3: 3 Top Dividend Stocks to Buy Right Now.NEWS4: 3 Top Dividend Stocks to Buy Right Now.NEWS5: [$$] Biogen and Abbvie Take Multiple Sclerosis Drug Off Market.NEWS6: 3 Top Dividend Stocks to Buy Right Now.NEWS7: Biogen, AbbVie pull multiple sclerosis drug from market amid safety concerns.NEWS8: Biogen, AbbVie to take multiple sclerosis drug off global market.NEWS9: Notable ETF Inflow Detected - MTUM, BA, ABBV, AMAT.NEWS10: Notable ETF Inflow Detected - MTUM, BA, ABBV, AMAT.NEWS11: Nasdaq, S&P 500 Turn Positive But Dow Closes Lower - U.S. Commentary.NEWS12: Nasdaq, S&P 500 Turn Positive But Dow Closes Lower - U.S. Commentary.NEWS13: Multiple Sclerosis Relapse Drug Is Pulled After Patient Safety Concerns.NEWS14: Biogen, AbbVie withdraw multiple sclerosis drug Zinbryta.NEWS15: 8 Dividend Payouts That Are Soaring on Tax Cuts.NEWS16: Major Averages Turn Mixed After Seeing Initial Weakness - U.S. Commentary.NEWS17: Major Averages Turn Mixed After Seeing Initial Weakness - U.S. Commentary.NEWS18: Biogen, AbbVie withdraw multiple sclerosis drug Zinbryta.NEWS19: Biogen and AbbVie Announce the Voluntary Worldwide Withdrawal of Marketing Authorizations for ZINBRYTA® (daclizumab) for Relapsing Multiple Sclerosis.NEWS20: Biogen, AbbVie Voluntarily Withdraw Worldwide MA For ZINBRYTA - Quick Facts.NEWS21: Biogen, AbbVie Voluntarily Withdraw Worldwide MA For ZINBRYTA - Quick Facts.

Answer: Rise